This hypothesis was then confirmed by our experiments, which suggested that upregulation of miR-29a-3p weakened the effect of KCNQ1OT1 upregulation on the growth of SEVO-treated HCC cells. Here, KCNQ1OT1 is linked to hepatocellular carcinoma.